ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

XCRP Xcorporeal Inc (CE)

0.0001
0.00 (0.00%)
13 Dec 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Xcorporeal Inc (CE) USOTC:XCRP OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.0001 0.00 00:00:00

- (25-NSE)

23/04/2010 3:29pm

Edgar (US Regulatory)


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 25

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number 001-33874

Issuer:  Xcorporeal, Inc.
Exchange:  NYSE Amex
(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)
Address:  12121 Wilshire Blvd.
Los Angeles,
CALIFORNIA
90025
Telephone number:  310-923-9990
(Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)
Common Stock, $0.0001 Par Value
(Description of class of securities)
Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:
o  17 CFR 240.12d2-2(a)(1)
o  17 CFR 240.12d2-2(a)(2)
o  17 CFR 240.12d2-2(a)(3)
o  17 CFR 240.12d2-2(a)(4)
x   Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. 1
o   Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.
Pursuant to the requirements for the Securities Exchange Act of 1934, NYSE Amex certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.
2010-04-23 By Janice O'Neill Senior Vice President, Corporate Compliance
Date Name Title
1 Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.

1 Year Xcorporeal (CE) Chart

1 Year Xcorporeal (CE) Chart

1 Month Xcorporeal (CE) Chart

1 Month Xcorporeal (CE) Chart

Your Recent History

Delayed Upgrade Clock